PL437191A1 - Formulacja do stosowania zewnętrznego oraz jej zastosowanie - Google Patents

Formulacja do stosowania zewnętrznego oraz jej zastosowanie

Info

Publication number
PL437191A1
PL437191A1 PL437191A PL43719121A PL437191A1 PL 437191 A1 PL437191 A1 PL 437191A1 PL 437191 A PL437191 A PL 437191A PL 43719121 A PL43719121 A PL 43719121A PL 437191 A1 PL437191 A1 PL 437191A1
Authority
PL
Poland
Prior art keywords
formulation
application
omega
external
fatty acids
Prior art date
Application number
PL437191A
Other languages
English (en)
Other versions
PL246051B1 (pl
Inventor
Bartosz BODNAR
Katarzyna WARZECHA
Original Assignee
Ester Labs OÜ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ester Labs OÜ filed Critical Ester Labs OÜ
Priority to PL437191A priority Critical patent/PL246051B1/pl
Priority to EP22159446.8A priority patent/EP4052763B1/en
Publication of PL437191A1 publication Critical patent/PL437191A1/pl
Publication of PL246051B1 publication Critical patent/PL246051B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Przedmiotem zgłoszenia jest formulacja do stosowania zewnętrznego zawierająca estry alkilowe wielonienasyconych kwasów tłuszczowych, charakteryzująca się tym, że zawiera estry etylowe wielonienasyconych kwasów tłuszczowych omega-3, omega-6 i omega-9 wyłącznie pochodzenia roślinnego, w stężeniu od 8% do 45% w odniesieniu do całkowitej masy formulacji. Zgłoszenie obejmuje także wyrób kosmetyczny lub wyrób medyczny zawierający odpowiednio, formulację kosmetyczną lub medyczną oraz zastosowanie formulacji.
PL437191A 2021-03-01 2021-03-01 Formulacja do stosowania zewnętrznego oraz jej zastosowanie PL246051B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL437191A PL246051B1 (pl) 2021-03-01 2021-03-01 Formulacja do stosowania zewnętrznego oraz jej zastosowanie
EP22159446.8A EP4052763B1 (en) 2021-03-01 2022-03-01 Formulation for external application and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437191A PL246051B1 (pl) 2021-03-01 2021-03-01 Formulacja do stosowania zewnętrznego oraz jej zastosowanie

Publications (2)

Publication Number Publication Date
PL437191A1 true PL437191A1 (pl) 2022-09-05
PL246051B1 PL246051B1 (pl) 2024-11-25

Family

ID=80735862

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437191A PL246051B1 (pl) 2021-03-01 2021-03-01 Formulacja do stosowania zewnętrznego oraz jej zastosowanie

Country Status (2)

Country Link
EP (1) EP4052763B1 (pl)
PL (1) PL246051B1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL448126A1 (pl) * 2024-03-28 2025-09-29 Uniwersytet Mikołaja Kopernika W Toruniu Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9201438A (nl) 1992-08-11 1994-03-01 Prospa Bv Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
US20110098495A1 (en) * 2009-10-27 2011-04-28 Chifu Huang Compositions and methods of omega polyunsaturated fatty acids for the treatment of oral diseases
US8927043B2 (en) * 2009-11-10 2015-01-06 Mycell Technologies Stabilized formulations of fatty acids
US20120213715A1 (en) * 2011-02-23 2012-08-23 Chifu Huang Method and composition for the prevention and treatment of early childhood dental caries
PL228401B1 (pl) * 2011-05-30 2018-03-30 Leenlife Polska Spolka Akcyjna Spożywczy środek prozdrowotny zawierający estry etylowe kwasów tłuszczowych zwłaszcza oleju lnianego i sposób jego otrzymywania
FI125743B (fi) * 2011-09-02 2016-01-29 Clanet Oy Rasvakoostumus iho-ongelmien ehkäisyyn tai hoitoon
US9585896B2 (en) 2012-04-04 2017-03-07 Pronova Biopharma Norge As Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof
RO129086B1 (ro) * 2012-06-08 2016-08-30 Suraki S.R.L. Procedeu pentru obţinerea esterilor etilici ai acizilor graşi omega 3, omega 6 şi omega 9 din uleiul rafinat de struţ
RO129084B1 (ro) * 2012-06-08 2016-08-30 Suraki S.R.L. Procedeu pentru obţinerea esterilor etilici ai acizilor graşi omega 3, omega 6 şi omega 9 din uleiul rafinat de urs
CN102994236B (zh) 2012-12-11 2015-03-25 成都圆大生物科技有限公司 一种制备Omega-3大于90%的脂肪酸乙酯的方法
PL228103B1 (pl) 2014-06-11 2018-02-28 Małgorzata Baszczok Sposób wytwarzania mieszaniny estrów etylowych roslinnych kwasów tłuszczowych o wysokiej zawartosci izomerów cis
CA3008039A1 (en) * 2015-12-10 2017-06-15 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof
US20190374552A1 (en) * 2016-11-02 2019-12-12 George Edward Hoag Multifunctional formulations and methods to control dermatitis and pruritus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL448126A1 (pl) * 2024-03-28 2025-09-29 Uniwersytet Mikołaja Kopernika W Toruniu Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo

Also Published As

Publication number Publication date
EP4052763B1 (en) 2025-12-24
PL246051B1 (pl) 2024-11-25
EP4052763A1 (en) 2022-09-07
EP4052763C0 (en) 2025-12-24

Similar Documents

Publication Publication Date Title
Mank et al. Use of natural oils as bioactive ingredients of cosmetic products
PH12017501328B1 (en) Self-emulsifying composition of ?-3 fatty acid
PH12017500074A1 (en) Nutritional compositions containing oil blends and uses thereof
EP4034069C0 (en) Hair cosmetic compositions containing fatty alcohol, gums, and esters
PH12016500100B1 (en) Self-emulsifying composition of omega3 fatty acid
DK2007214T3 (da) Spiselige produkter med lavt indhold af mættede og trans-umættede fedter
MX2023013976A (es) Composicion de grasa y emulsion de agua en aceite.
PH12020551796A1 (en) Branched fatty acids and esters thereof
EP3733857A3 (en) Dihomo-gamma-linolenic acid-containing microbial oil and dihomo-gamma-linolenic acid-containing microbial biomass
PL437191A1 (pl) Formulacja do stosowania zewnętrznego oraz jej zastosowanie
GEAP202315725A (en) Pharmaceutical composition comprising omega fatty acids, and infusion preparation comprising the same
KR20130084589A (ko) 유화 화장료
ÇAKMAKÇI et al. Yağ asitlerinin sağlık ve beslenme üzerine etkileri
MX353138B (es) Emulsion de aceite en agua que comprende al menos una mezcla especifica de tensioactivos no ionicos, una cera que comprende al menos un ester y un polisacarido soluble en agua.
PE20211003A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
MX2020002253A (es) Una composicion para el cuidado personal.
PH12020550961A1 (en) Stabilizing omega-3 fatty acids with bran
Priya et al. Potential testing of fatty acids from mangrove Aegiceras corniculatum (L.) Blanco
CL2016003044A1 (es) Composiciones estructuradas de grasa vegetal, proceso para obtener dicha composición estructurada de grasas, uso de la composición estructurada de grasas en la preparación de una composición cosmética, composición cosmética y producto que comprende dicha composición estructurada de grasas
HRP20220808T1 (hr) Formulacija na bazi vitamina e ili njegovog estera za liječenje bakterijskih i gljivičnih biofilmova
Loumouamou et al. Extraction and Chemical composition of seed kernel oil from Irvingia smithii of Congo Basin
CL2021000520A1 (es) Una composición que contiene hierro y uso de la misma
JP2013139395A (ja) 水中油型乳化組成物
PH12020550697A1 (en) Cosmetic compositions comprising silicone elastomer and emollient
EA202090849A1 (ru) Стабильные водные растворы, содержащие пнжк